What duration do you feel comfortable maintaining for the pediatric population on topical calcineurin inhibitors?

Topical calcineurin inhibitors are safe and effective for both the treatment and maintenance of atopic dermatitis in the pediatric population. The FDA approval age for topical tacrolimus is 2, however, many pediatric dermatologists and general dermatologists safely use these medications off-label in younger patients. While not as effective as topical steroids in reducing inflammation related to an acute flare of eczema, topical calcineurin inhibitors enjoy a superior safety profile to topical st...